(±)-N-(2,6-Dimethylphenyl)-1-iso-propyl-d7-2-piperidinecarboxamide

(±)-N-(2,6-Dimethylphenyl)-1-iso-propyl-d7-2-piperidinecarboxamide, also known as Dimebolin-d7, is a deuterated analogue of Dimebolin, a drug that was originally developed as an antihistamine and later found to have potential therapeutic effects for treating Alzheimer's disease. Dimebolin-d7 is primarily used as an analytical reference standard for research purposes. Chemically, Dimebolin-d7 is a piperidine derivative with a molecular formula of C19H24D7N2O and a molecular weight of 301.49 g/mol. It is a white to off-white powder that is soluble in organic solvents such as methanol and ethanol. Dimebolin-d7 has been used in various studies to investigate its pharmacological properties, such as its ability to modulate neurotransmitter activity and its effects on cognitive function. It has also been used as a chemical probe in drug discovery efforts aimed at identifying new therapeutic agents for the treatment of Alzheimer's disease. While Dimebolin-d7 has shown promise in preclinical studies, its use in humans has been limited due to safety concerns and lack of efficacy in clinical trials. Nonetheless, it remains an important analytical tool for researchers studying the mechanisms of action of potential Alzheimer's disease therapies.